lsuhsc2Lousiana State University Health Sciences Center New Orleans (LSUHSC) educates Louisiana’s health care professionals. The state’s academic health leader, LSUHSC comprises a School of Medicine, the state’s only School of Dentistry, Louisiana’s only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. Louisiana’s flagship academic health center, LSUHSC faculty takes care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease.

To learn more, visit and

Tumor Registry

LSUHSC’s Louisiana Tumor Registry is one of the 18 competitively awarded cancer registries in the SEER (Surveillance, Epidemiology and End Results) Program of the National Cancer Institute. The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States.

Cancer Research Advancements & Achievements

achievementLSUHSC Cancer Center researchers have submitted two major patents, one aimed at controlling the growth of viruses with a newly discovered natural enzyme.  This discovery could be applied for the prevention and treatment of infections such as the new forms of influenza and the prevention of cancer.  The second patent is the development of a new mouse containing the human immune system, which allows investigators to use this mouse model to test new forms of immune therapies in cancer and other diseases.  Both discoveries have been favorably evaluated for funding at the National Institutes of Health.

LSUHSC Cancer Center researchers discovered how an enzyme produced by cells of the immune system can be used in the treatment of T cell leukemias, an aggressive type of leukemia that is particularly difficult to treat in adult patients.  They are now testing this new treatment for solid tumors of the lung and liver.

LSUHSC Cancer Center scientists have revealed, for the first time, the inner workings of a master gene regulator. It controls functions as diverse as the ability of nerve cells to “rewire” themselves in response to external stimuli and the mechanism by which certain viruses hijack the normal response of the immune system. Viruses can then replicate inside the cells ultimately leading to cancer.

LSUHSC Cancer Center researchers have shown that a master gene controlling how fast cancer cells divide is also essential in regulating the immune response to cancer.

The LSUHSC Viruses and Cancer Group received coveted admission to the AIDS Malignancy Consortium (AMC) funded by the National Cancer Institute. This consortium develops and makes available state-of-the-art cancer treatment for patients with HIV-AIDS and cancer who require specialized care. The LSUHSC Viruses and Cancer Group is the only member of the AMC in the Deep South.

LSUHSC researchers also developed one of the world’s most successful pediatric weight management programs, cited by the National Cancer Institute as a gold standard for risk reduction.

Meet the LSUHSC Research Team…


No Smoking SignLSUHSC was the the first to link cigarette smoking to hardening of the arteries – the major cause of heart disease. 

They also conducted a landmark study showing that second-hand smoke can cause lung cancer in people who have never smoked. These findings led the Environmental Protection Agency to designate second-hand smoke as a Class A carcinogen.

  • Developed a new class of pain relievers without toxicity to the liver or kidneys.
  • Discovered the link between treatable bacteria – Helicobacter pylori – and stomach cancer.
  • Discovered genes involved in deafness in various ethnic groups as well as for Friedreich Ataxia and Usher Syndrome.
  • Discovered the first retrovirus proteases in mammals and contributed to the development of the first HIV protease inhibitors.
  • Discovered early predictors of the metabolic syndrome in healthy 7-9 year-olds.
  • Showed a component of fish oil given up to 5 hours after a stroke limits brain damage.
  • Conducted a landmark study proving that atherosclerosis begins in childhood.
  • Developed an application method for delivering dental cement in tiny crevices, making it possible to save teeth that would have previously been lost.